The ATAMIS (Antiplatelet Therapy in Acute Mild to Moderate Ischemic Stroke) trial demonstrated that DAPT reduces the risk of END at 7 days for patients with mild to moderate ischemic stroke. Another ...

Background and purpose Thromboembolic events are recognized complications of aneurysm coiling. Objective To identify any protective effects of antiplatelet therapy use before coiling of unruptured ...

Combination therapy with a statin plus an intestinal agent can be used in individuals that can only tolerate a low-dose statin or an intermittent dosing of the statin. The combination of a statin ...

Creative Commons (CC): This is a Creative Commons license. Attribution (BY): Credit must be given to the creator. Percutaneous coronary intervention administration of statins enhances the ...

Background: Statins are generally well tolerated, but some patients discontinue therapy secondary to adverse effects. Dosing a statin (rosuvastatin) every other day (EOD) may provide significant ...

Research is unclear on whether CoQ10 supplements can help your heart health or help relieve muscle pain from statin medications. Your doctor can best determine if you may benefit from taking both ...

Researchers found that a combination therapy of two drugs disrupts this pathway, helping to suppress the creation of cancer cells and tumor growth. This combo of medications includes a statin ...

Background Antiplatelet therapy (APT) can substantially reduce the risk of further vascular ... Details of the study methods and data have been described previously in an analysis of statin therapy ...

The stepwise approach described herein aims to reflect how we assess patients in everyday practice who require perioperative anticoagulant or antiplatelet management. Is the interruption of ...

2 The Copenhagen City Heart Study, Frederiksberg Hospital, Copenhagen, Denmark 3 The Copenhagen General Population Study, Herlev Hospital, Copenhagen University Hospital, University of Copenhagen, ...

Feb. 3, 2025 — Low-density lipoproteins (LDL) -- commonly known as bad cholesterol -- have long been on scientists' radar as a major contributor to heart disease. But these microscopic ...